Sagility Unveils AI-Powered Growth Plan at Investor Day

Sagility Limited held its Investor & Analyst Day on March 25, 2026, where leadership detailed the company's strategy to use Artificial Intelligence (AI) and advanced platforms for growth. CEO Ramesh Gopalan and CFO Srinivas Mattapalli presented the company's vision.

Sagility's Core Business and Performance

The company serves 100% US healthcare clients, with 87-88% of its revenue derived from Payers and the remainder from Providers. Sagility maintains stable EBITDA margins in the 24-25% range and has a five-year track record of double-digit growth.

AI as a Growth Engine

Management highlighted a strategic shift from traditional FTE (full-time equivalent) models to outcome-based managed services and proprietary 'Synchrony' platforms. This shift aims to leverage industry tailwinds, such as client margin compression (rising Medical Loss Ratios - MLRs), which boosts demand for Sagility's cost-reduction services.

The company sees AI as a 'force multiplier,' automating complex workflows and increasing deal sizes. For instance, Sagility scaled a $6 million deal to $20 million by handling onshore work with Gen AI agents. This strategy aims to capture higher-value onshore processes, helping offset revenue erosion from automation in traditional BPO work.

Differentiating Factor

Sagility differentiates itself by blending technology with clinical service delivery, taking accountability for final business outcomes – unlike many platform providers. This approach is key in the US healthcare market, where client margin compression drives demand for efficiency solutions.

Company Background and Client Relationships

Sagility, formerly Berkmeer India Pvt. Ltd., was incorporated in July 2021. It provides business process management (BPM) and revenue cycle management (RCM) services for US healthcare.

The company has consistently invested in advanced technologies like AI and machine learning to improve its services and client outcomes. Its strategy builds on strong, long-standing client relationships—top clients average 18 years of tenure—by offering tailored, value-driven services for sustained retention. Sagility's AI platform, Nurse Assist, won an AI Excellence Award for transforming prior authorization processes with high accuracy and cost savings.

Key Strategic Directions

• Accelerated AI Adoption: Greater focus on AI as a 'force multiplier' for efficiency and new service opportunities.
• Outcome-Based Models: Shifting from FTE to managed services and platforms, linking fees to client business outcomes.
• Enhanced Client Value: Using client margin pressures to offer cost-reduction services and strengthen relationships.
• Guidance Update: Investors await specific financial guidance in May 2026 to assess growth projections.
• Risk Mitigation: Continued focus on managing risks from Medicaid funding, regulatory complexity, and AI model integrity.

Potential Risks

• Medicaid Funding Cuts: Member losses for Medicaid-heavy health plans could affect Sagility's client base.
• Regulatory Complexity: US laws like HIPAA might restrict AI deployment speed and autonomy.
• AI Technical Risks: Risks of AI 'hallucination' and 'drift' require ongoing human oversight.

Competitive Landscape

Sagility competes with players like WNS Global Services, Genpact, and Infosys BPM in the healthcare BPM space.

What to Watch Next

• Specific financial guidance expected in May 2026 for growth projections.
• Successful scaling of AI-driven deals and adoption of new AI agents.
• Management's ability to navigate Medicaid funding shifts and regulatory hurdles.
• Client acquisition and deepening relationships with existing payers and providers.
• Competitive response from peers in AI and outcome-based services.
• Impact of AI 'hallucination' and 'drift' risks on service delivery and client satisfaction.